Quarterly Results
BLSH Earnings Forecast
Looking ahead, BLSH remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of and an EPS of .
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 7.01%, while EPS estimates have been Revise Upward by 14.13%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Upward by 13.59% . These revisions correlate with a -36.43% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in BLSH long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
1Y
3Y
5Y
Currency: USD
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price0

No data
Earnings Surprise Analysis
Revenue
EPS
1Y
3Y
Al Analysis
Earnings Reaction
The chart below shows how BLSH performed 10 days before and after its earnings report, based on data from the past quarters. Typically, BLSH sees a -0.17% change in stock price 10 days leading up to the earnings, and a +11.89% change 10 days following the report. On the earnings day itself, the stock moves by +5.82%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in JUN/2025, the stock changed 20.72% on the day following the earnings release and then changed by 11.89% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
People Also Watch
Frequently Asked Questions
What were the key highlights of BLSH's latest earnings report for ?
BLSH reported its earnings on 2025-09-17, showcasing a revenue of 57.00M against an estimate of 55.75M, resulting in a 2.25% surprise. The EPS was -0.05, surpassing the expected -0.05 by 0% . The stock experienced a 20.72% price change on the earnings day and a 27.86% change over the next five days, reflecting market reactions to the results.
How did BLSH's stock price react after the earnings release?
Following BLSH's earnings announcement on 2025-09-17, the stock price moved by 20.72% on the day of the release. Over the subsequent five days, it saw a 27.86% change. Historically, BLSH's stock price tends to shift by an average of -0.17% in the 10 days leading up to earnings and +11.89% in the 10 days following, providing insight into potential market.
What are the revenue and EPS estimates for BLSH for undefined?
For , analysts estimate BLSH’s annual revenue to reach , while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 7.01% and EPS estimates Revise Upward by 13.59% over the past three months, indicating analyst expectation in the company’s performance.
How does BLSH's stock price correlate with earnings forecast revisions?
The correlation between BLSH's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 7.01%, while EPS estimates moved Revise Upward by 13.59% . This trend suggests that price dips could present buying opportunities for investors.
What should investors expect from BLSH's next earnings report?
Based on historical trends, BLSH's stock price typically moves by -0.17% in the 10 days before its earnings and +11.89% in the 10 days after. For the upcoming earnings, analysts expect an EPS of and revenue of .
What is the sentiment in Bullish (BLSH) Q3 2025 Earnings Call Summary?
The earnings call highlights strong financial performance with record net income and significant revenue growth. The company has strategic plans for U.S. market entry and options trading, bolstered by regulatory approvals. Despite some challenges like customer onboarding and market volatility, management is optimistic about regulatory developments and partnerships. The Q&A reveals positive sentiment towards the company's strategic initiatives and regulatory achievements, despite some vague responses. Overall, the strong financial metrics and strategic advancements suggest a positive outlook for the stock price.

